These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6633816)

  • 1. Does DDAVP (1-desamino-8-D-arginine-vasopressin) cross the blood-CSF barrier?
    Stegner H; Artman HG; Leake RD; Fisher DA
    Neuroendocrinology; 1983 Oct; 37(4):262-5. PubMed ID: 6633816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.
    Stegner H; Artman HG; Leake RD; Fisher DA
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):204-6. PubMed ID: 6495988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus.
    Sørensen PS; Vilhardt H; Gjerris F; Warberg J
    Eur J Clin Invest; 1984 Dec; 14(6):435-9. PubMed ID: 6441719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog.
    Ang VT; Jenkins JS
    J Endocrinol; 1982 Jun; 93(3):319-25. PubMed ID: 7086325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on vasopressin release and blood pressure during hemorrhage.
    Shimizu K; Nakao A
    Endocrinol Jpn; 1992 Oct; 39(5):517-23. PubMed ID: 1478192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.
    Lundin S; Melin P; Vilhardt H
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):179-83. PubMed ID: 3969814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect.
    Albuquerque CA; Nijland MJ; Ross MG
    J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged antidiuresis by 1-desamino-8-D-arginine vasopressin (DDAVP): correlation to its plasma levels and nephrogenous cyclic AMP production.
    Katayama S; Itabashi A; Yamaji T
    Endocrinol Jpn; 1980 Jun; 27(3):363-70. PubMed ID: 6254752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of AVP and DDAVP on plasma renin activity and electrolyte excretion in conscious dogs.
    Johnson MD; Kinter LB; Beeuwkes R
    Am J Physiol; 1979 Jan; 236(1):F66-70. PubMed ID: 434155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
    Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
    J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 1-desamino-8-D-arginine vasopressin (DDAVP) in patients with central diabetes insipidus.
    Pullan PT; Burger HG; Johnston CI
    Clin Endocrinol (Oxf); 1978 Sep; 9(3):273-8. PubMed ID: 709897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDAVP-induced maternal hyposmolality increases ovine fetal urine flow.
    Nijland MJ; Ross MG; Kullama LK; Bradley K; Ervin MG
    Am J Physiol; 1995 Feb; 268(2 Pt 2):R358-65. PubMed ID: 7864229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.
    Marchingo AJ; Abrahams JM; Woodcock EA; Smith AI; Mendelsohn FA; Johnston CI
    Endocrinology; 1988 Apr; 122(4):1328-36. PubMed ID: 2964362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the renal concentration capacity following intravenous administration of dDAVP in healthy humans.
    Faerch M; Schroeder MK; Mahler BT; Christensen JH; Kamperis K; Rittig S
    Scand J Clin Lab Invest; 2018; 78(1-2):114-119. PubMed ID: 29361858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urinary excretion of selenium in sheep treated with a vasopressin analogue.
    Leng L; Boldizárová K; Faix S; Kovác G
    Vet Res; 2000; 31(5):499-505. PubMed ID: 11050745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between a synthetic analogue of vasopressin and human peripheral blood lymphocytes.
    Wickramasinghe SN; Valdimarsson H; Williams B
    J Clin Lab Immunol; 1982 Jan; 7(1):67-70. PubMed ID: 6279851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
    Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability].
    Tuschy U; Szeszat S; Rindfleisch U
    Z Gesamte Inn Med; 1984 Jun; 39(11):265-8. PubMed ID: 6475171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.